MUSC Libraries Logo

Publications - 2004


Displaying Publications 451 thru 501 (1580; Publications found in database)
[Previous] [Next]
[Search (1993 to Present)]
[Back to Menu]

Giri Shailendra, Nath Narendra, Smith Brian, Viollet Benoit, Singh Avtar K., Singh Inderjit. 5-aminoimidazole-4-carboxamide-1-b-4-ribofuranoside inhibits proinflammatory response in glial cells: A possible role of AMP-activated protein kinase. Journal of Neuroscience 2004; 24 (2):479-487.
Givens M., Lapointe M.. Is there a place for epoetin alfa in managing anemia during critical illness?. Clin. Ther. 2004; 26 (6):819-29.
Givens M., Lapointe M.. Is there a place for epoetin alfa in managing anemia during critical illness?. Clinical Therapeutics 2004; 26 (6):819-29.
Glaser J.. Stabilization of the C1-C2 articulation. Southern Medical Journal 2004; 97 (11):1030-1030.
Glaser J. A., Keffala V., Spratt K.. Weather conditions and spinal patients. Spine 2004; 29 (12):1369-73; discussion 1374.
Glaser J. A., Keffala V., Spratt K.. Weather conditions and spinal patients. Spine 2004; 29 (12):1369-1373.
Gold M. R., Peters R. W.. Newer Applications of Pacemakers. In: Zipes D.P., Jalife J., editors. Cardiac Electrophysiology: Fourth Edition. New York: Elsevier, 2004. p. 1011-1017. doi: 10.1016/B0-7216-0323-8/50113-5
Gold P. B.. Some obstacles to employment for persons with chronic substance use disorders. Substance Use and Misuse 2004; 39 (13-14):2631-2636.
Gold P. B., Meisler N., DuRoss D., Bailey L.. Employment outcomes for hard-to-reach persons with chronic and severe substance use disorders receiving assertive community treatment. Substance Use and Misuse 2004; 39 (13-14):2425-2489.
Gold Paul B.. Some obstacles to employment for persons with chronic substance use disorders. Substance Use and Misuse 2004; 39 (13-14):2631-2636.
Gold Paul B., Meisler Neil, DuRoss Deborah, Bailey Linda. Employment outcomes for hard-to-reach persons with chronic and severe substance use disorders receiving assertive community treatment. Substance Use and Misuse 2004; 39 (13-14):2425-2489.
Goldstein S., Barkley Russell A.. Talking to parents about ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2004; 43 ():648-649.
Goletz P. W., Crouch R. K., Lewis M. R., Kono M., Estevez M., Cornwall M. C.. Differences in salamander red cone and blue cone/green rod pigments. Investigative Ophthalmology and Visual Science 2004; 45 ():U182-U182.
Gonsalves W. C., Skelton J., Smith T., Hardison D., Ferretti G.. Physicians Oral Health Education in Kentucky. Family Medicine 2004; 36 (8):544-546.
Gooz M., Toth M., Vakkuri O., Gooz P., Smolka A. J., de Chatel R., Szalay K. S.. Endogenous ouabain-like factor (OLF) secretion is modulated by nicotinic mechanisms in rat adrenocortical cells. Life Sciences 2004; 74 (17):2111-2128.
Gooz M., Vakkuri O., de Chatel R., Szalay K. S., Toth M.. Elevated blood levels of endogenous ouabain-like factor in preterm versus mature newborns at birth. Biology of the Neonate 2004; 85 (3):155-158.
Gordon D., Haynes C., Johnnidis C., Patel S. B., Bowcock A. M., Ott J.. A transmission disequilibrium test for general pedigrees that is robust to the presence of random genotyping errors and any number of untyped parents. European Journal of Human Genetics 2004; 12 (9):752-761.
Gore J., Silver R.. Oral sildenafil for treatment of Raynaud phenomenon and digital ulcers secondary to scleroderma (systemic sclerosis). Arthritis and Rheumatism 2004; 50 (12):4085-4086.
Gourdie R. G., Watanabe M.. Excited by the cardiac pacemaking and conduction system. Anatomical Record Part a-Discoveries in Molecular Cellular and Evolutionary Biology 2004; 280A (2):933-933.
Graber D. R., Jones W. J., Johnson J. A.. Human and ecosystem health: the environment-agriculture connection in developing countries. Journal of Agromedicine 2004; 9 (2):131-46.
Graber D. R., Mitcham M. D.. Compassionate clinicians: take patient care beyond the ordinary. Holist. Nurs. Pract. 2004; 18 (2):87-94.
Graber D. R., Mitcham M. D.. Compassionate clinicians: take patient care beyond the ordinary. Holist. Nurs. Pract. 2004; 18 (2):87-94.
Graham Solomons J. T., Zimmerly E. M., Burns S., Krishnamurthy N., Swan M. K., Krings S., Muirhead H., Chirgwin J., Davies C.. The crystal structure of mouse phosphoglucose isomerase at 1.6A resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening. Journal of Molecular Biology 2004; 342 (3):847-60.
Graham E. M., Bradley S. M., Shirali G. S., Hills C. B., Atz A. M., Consortium Pediatric Cardiac Care. Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). American Journal of Cardiology 2004; 93 (6):801-3.
Gray M. J., Elhai J. D., Frueh B. C.. Enhancing patient satisfaction and increasing treatment compliance: Patient education as a fundamental component of PTSD treatment. Psychiatric Quarterly 2004; 75 ():321-332.
Gray Matt J., Elhai Jon D., Frueh B. Christopher. Enhancing patient satisfaction and increasing treatment compliance: Patient education as a fundamental component of PTSD treatment. Psychiatric Quarterly 2004; 75 (4):321-332.
Green M. R.. Targeting targeted therapy. New England Journal of Medicine 2004; 350 (21):2191-3.
Greig N. H., Giordano T., Zhu X. X., Yu Q. S., Holloway H. W., Brossi A., Sambamurti K., Lahiri D. K.. Novel TNF-alpha inhibitors for neurodegeneration: 3-phthalimidoglutarimide analogues. Neurobiology of Aging 2004; 25 ():S199-S199.
Greig N. H., Mattson M. P., Perry T., Chan S. L., Giordano T., Sambamurti K., Rogers J. T., Ovadia H., Lahiri D. K.. New therapeutic strategies and drug candidates for neurodegenerative diseases p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Annals of the New York Academy of Sciences 2004; 1035 ():290-315.
Greig N. H., Utsuki T., Wang Y., Ingram D. K., Mamczar J., Rogers J., Yu Q. S., Holloway H. W., Perry T., Sambamurti K., Scali C., Pepeu G., Lahiri D. K.. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers amyloid-beta peptide in rodents: A new treatment strategy for Alzheimer's disease. Neurobiology of Aging 2004; 25 ():S216-S216.
Grenesko E. L., Molnar C., Mishory A., Anderson B., Nahas Z., Horner M., George M. S.. Sleep deprivation, cortical excitability and working memory. Psychophysiology 2004; 41 ():S53-S53.
Griffin W. C., Middaugh L. D., Cook J. E., Tyor W. R.. The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: Deficits in cognitive function. Journal of Neurovirology 2004; 10 (2):109-115.
Grimes A. C., Zdanowicz M., Li Y., Kirby M. L.. Striated to smooth muscle transition in the developing zebrafish cardiac outflow tract. Molecular Biology of the Cell 2004; 15 ():214A.
Gross R. H.. The coaching model for educational leadership principles. Journal of Bone and Joint Surgery American 2004; 86-A (9):2082-4.
Gross R. H.. Sports medicine in youth athletes. Southern Medical Journal 2004; 97 (9):880.
Grubaugh A. L., Elhai J. D., Monnier J., Frueh B. C.. Service utilization among compensation-seeking veterans. Psychiatric Quarterly 2004; 75 (4):333-41.
Grubaugh Anouk L., Elhai Jon D., Monnier Jeannine, Frueh Christopher. Service utilization among compensation-seeking Veterans. Psychiatric Quarterly 2004; 75 (4):333-341.
Guo G., Bhat N. R.. Glutamate release and hypoxia-induced motoneuronal cell death. Journal of Neurochemistry 2004; 90 ():14.
Gupta R., Hollis B. W., Patel S. B., Patrick K. S., Bell N. H.. CYP3A4 is a human microsoma vitamin D 25-hydroxylase. Journal of Bone and Mineral Research 2004; 19 (4):680-688.
Gustafson K. K., Summer A. P., Darden P. M.. Do children without a regular doctor use the emergency department more often?. Pediatric Research 2004; 55 (4):119A-119A.
Guyton M. K., Rohrer B., Crosson C., Banik N. L.. Neurodegeneration of the optic nerve occurs in EAE, an animal model of optic neuritis. Investigative Ophthalmology and Visual Science 2004; 45 ():U210-U210.
Guyton M. K., Wingrave J. M., Sribnick E. A., Matzelle D. D., Ray S. K., Banik N. L.. Up-regulation of calpain correlates with increased axonal degeneration and neuronal death in experimental allergic encephalomyelitis. Journal of Neurochemistry 2004; 90 ():50.
Hadden M. K., Dix T. A.. Evaluation of the antipsychotic potential of novel, orally bioavailable, neurotensin analogues containing non-natural arginine and lysine residues. Abstracts of Papers of the ACS Meeting 2004; ():MEDI-272.
Hadden M. K., Dix T. A.. Evaluation of the antipsychotic potential of novel, orally bioavailable, neurotensin analogues containing non-natural arginine-and lysine residues. Abstracts of Papers of the American Chemical Society 2004; 227 ():U57-U57.
Hall P. D., Patala A., Frankel A.. Contribution of anti-DT IgG from platelet transfusions and FFP. Pharmacotherapy 2004; 24 (10):1451-1451.
Halliday-Boykins C. A.. Commentary: Antisocial behaviour-multidetermined across cultures. International Journal of Epidemiology 2004; 33 (5):1052-1052.
Halliday-Boykins C. A., Henggeler S. W., Rowland M. D., DeLucia C.. Heterogeneity in youth symptom trajectories following psychiatric crisis: Predictors and placement outcomes. Journal of Consulting and Clinical Psychology 2004; 72 (6):993-1003.
Ham L. S., Carrigan M. H., Randall C. L.. Social anxiety and positive alcohol expectancies. Alcoholism-Clinical and Experimental Research 2004; 28 (5):144A-144A.
Hama H., Torabinejad J., Prestwich G. D., DeWald D. B.. Measurement and immunofluorescence of cellular phosphoinositides. Methods in Molecular Biology 2004; 284 ():243-258.
Hammer Mark B., Robert Sophie, Frueh B. Christopher. Treatment-resistant posttraumatic stress disorder: Strategies for intervention. CNS Spectrums 2004; 9 (10):740-752.
[Previous] [Next]
[Search (1993 to Present)]
[Back to Menu]